{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:23:41Z","timestamp":1649125421088},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1993,6,1]],"date-time":"1993-06-01T00:00:00Z","timestamp":738892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biotherapy"],"published-print":{"date-parts":[[1993,6]]},"DOI":"10.1007\/bf01877428","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T16:43:36Z","timestamp":1120495416000},"page":"149-153","source":"Crossref","is-referenced-by-count":0,"title":["Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemia"],"prefix":"10.1007","volume":"6","author":[{"given":"Shigeru","family":"Arimori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozou","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Omine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01877428_CR1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198105213042105","volume":"304","author":"HP Koeffler","year":"1981","unstructured":"Koeffler HP, Golde DW. Chronic myelogeneous leukaemia: new concepts. N. Engl J Med 1981; 304: 1269\u201374.","journal-title":"N. Engl J Med"},{"key":"BF01877428_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.1981.tb02765.x","volume":"47","author":"S Tura","year":"1981","unstructured":"Tura S, Baccarani M, Corbelli G. The Italian cooperative study group on chronic myeloid leukemia. Staging of chronic myeloid leukaemia. Brit J Haemat 1981; 47: 105\u2013119.","journal-title":"Brit J Haemat"},{"key":"BF01877428_CR3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1924.02650450001001","volume":"82","author":"GR Minot","year":"1924","unstructured":"Minot GR, Buckman TE, Isaacs R. Chronic myelogenous leukaemia: age, incidence, duration and benefit derived from irradiation, J A M A 1924; 82: 1489\u20131494.","journal-title":"J A M A"},{"key":"BF01877428_CR4","first-page":"207","volume":"21","author":"P Jacobs","year":"1975","unstructured":"Jacobs P, Dubovsky D, King H, Sealey R. Splenic irradiation in the management of chronic granulocytic leukaemia. Cent Afri J Med 1975; 21: 207\u2013210.","journal-title":"Cent Afri J Med"},{"key":"BF01877428_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bmj.1.5586.201","volume":"1","author":"Medical Research Council's Working Party for Therapeutic Trials in Leukaemia","year":"1968","unstructured":"Medical Research Council's Working Party for Therapeutic Trials in Leukaemia. Chronic granulocyte leukaemia: comparison of radiotherapy and busulfan therapy. Brit Med J 1968; 1: 201\u2013208.","journal-title":"Brit Med J"},{"key":"BF01877428_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7326\/0003-4819-50-4-942","volume":"50","author":"EH Reinhard","year":"1959","unstructured":"Reinhard EH, Neely L, Samples DM. Radioactive phosphorus in the treatment of chronic leukaemias: long-term results over a period of 15 years. Ann Int Med 1959; 50: 942\u2013958.","journal-title":"Ann Int Med"},{"key":"BF01877428_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V17.1.1.1","volume":"17","author":"A Haut","year":"1961","unstructured":"Haut A, Abbott WS, Wintrobe MM, Cartwright GE. Busulfan in the treatment of chronic myelocytic leukaemia. The effect of long term intermittent therapy. Blood 1961; 17: 1\u201319.","journal-title":"Blood"},{"key":"BF01877428_CR8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19871001)60:7<1442::AID-CNCR2820600706>3.0.CO;2-W","volume":"60","author":"RT Silver","year":"1987","unstructured":"Silver RT, Mick R, Cooper R, Ellison RR, Levy R, Brunner K, Schwartz JM, Holland JF. Comparative study of dibromomannitol and busulfan in the treatment of chronic myeloid leukaemia. A study of cancer and leukaemia group. Cancer 1987; 60: 1442\u20131448.","journal-title":"Cancer"},{"key":"BF01877428_CR9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/bmj.1.5855.700","volume":"1","author":"L Schwarzenberg","year":"1973","unstructured":"Schwarzenberg L, Mathe G, Pouillart P, Weiner R, Locour J, Genin JL, Schneider M, deVasal F, Hayat M, Amiel JL, Schlumberger JR, Jasmin C, Rosenfeld C. Hydroxyurea, leukapheresis, and splenectomy in chronic myeloid leukaemia at the pro-blastic phase. Brit Med J. 1973; 1: 700\u2013703.","journal-title":"Brit Med J"},{"key":"BF01877428_CR10","first-page":"121","volume":"8","author":"S Tura","year":"1975","unstructured":"Tura S, Baccarini M, Gugliotta L, Lauria F, Fiacchini M, Tomasini I. A clinical trial of early splenectomy, hydroxyurea, and cyclic arabinosylcytosine, vincristine, and prednisone in chronic myeloid leukaemia. Ser Haematol. 1975; 8: 121\u2013142.","journal-title":"Ser Haematol"},{"key":"BF01877428_CR11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.1985.3.2.192","volume":"3","author":"HM Kantarjian","year":"1985","unstructured":"Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hestner J, Smith T, Barlogie,. Trujullo J, Freireich EJ. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukaemia. J Clin Oncol 1985; 3: 192\u2013200.","journal-title":"J Clin Oncol"},{"key":"BF01877428_CR12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2141.1983.tb02116.x","volume":"54","author":"Medical Research Council's Working Party for Therapeutic Trials in Leukaemia","year":"1983","unstructured":"Medical Research Council's Working Party for Therapeutic Trials in Leukaemia. Randomized trial of splenectomy in Ph1-positive chronic granulocytic leukaemia, including an analysis of prognostic features. Brit J Haemat 1983; 54: 415\u2013430.","journal-title":"Brit J Haemat"},{"key":"BF01877428_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1056\/NEJM198601233140403","volume":"314","author":"JM Goldman","year":"1986","unstructured":"Goldman JM, Apperley JF, Jones L, Marcus R, Goolden AWG, Batchelor R, Hale G, Waldmann H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton AG. Bone marrow transplantation for patients with chronic myeloid leukaemia. N Engl J Med 1986; 314: 202\u2013207.","journal-title":"N Engl J Med"},{"key":"BF01877428_CR14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood.V56.3.356.356","volume":"56","author":"JW Singer","year":"1980","unstructured":"Singer JW, Arlin ZA, Najfeld V, Adamson JW, Kempin SJ, Clarkson BD, Fialkow PJ. Restoration of nonclonal hematopoiesis in chronic myelogenous leukaemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood 1980; 56: 356\u2013360.","journal-title":"Blood"},{"key":"BF01877428_CR15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","volume":"314","author":"M Talpaz","year":"1986","unstructured":"Talpaz M, Kantarjian HM, McKredie K, Trujillo JM, Keating MJ, Gutterman J. Hematologic remission and cytogenetic improvement induced by recombinant interferon alpha in chronic myelogenous leukaemia. N Engl J Med 1986; 314: 1065\u20131069.","journal-title":"N Engl J Med"},{"key":"BF01877428_CR16","first-page":"359","volume-title":"Pharmacological Treatment of Cancer: Development and Judgement of Effects","author":"I Kimura","year":"1985","unstructured":"Kimura I, Kitajima K. Chronic leukaemia. In: Saito T. eds. Pharmacological Treatment of Cancer: Development and Judgement of Effects. Tokyo: Realize Inc. 1985: 359\u2013366."},{"key":"BF01877428_CR17","first-page":"2959","volume":"15","author":"S Koyama","year":"1988","unstructured":"Koyama S, Moriyama Y, Shibata A, Miura Y, Abe T, Asano S, Miyazaki T, Miura A, Kariyone S, Toyama K, Hirano M, Furuta S, Ohta T, Takino T, Maekawa T, Hayashi H, Haruyama H, Hosoda S, Masaoka T, Kuramoto A, Kamata N, Oguma N, Ishimaru M. Clinical investigation of natural interferon alpha (HLBI) in chronic myelogenous leukaemia. A multi-institutional cooperative study in Japan. Jpn J Cancer Chemother 1988; 15: 2959\u20132968.","journal-title":"Jpn J Cancer Chemother"},{"key":"BF01877428_CR18","first-page":"205","volume":"53","author":"JC Hozler","year":"1980","unstructured":"Hozler JC, Lindquist LL. Banded karyotypes from bone marrow. A clinically useful approach. Human Genet 1980; 53: 205\u2013209.","journal-title":"Human Genet"},{"key":"BF01877428_CR19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V58.5.1050.1050","volume":"58","author":"PB McGrlave","year":"1981","unstructured":"McGrlave PB, Miller WJ, Hurd DD, Arthur DC, Kim T. Cytogenetic conversion following allogeneic bone marrow transplantation for advanced chronic myelogenous leukaemia. Blood 1981; 58: 1050\u20131052.","journal-title":"Blood"},{"key":"BF01877428_CR20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.V73.8.2165.2165","volume":"73","author":"M-S Lee","year":"1989","unstructured":"Lee M-S, LeMaistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA. Detection of two alternative bcr\/abl mRNA junction and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukaemia by polymerase chain reaction. Blood 1989; 73: 2165\u20132170.","journal-title":"Blood"},{"key":"BF01877428_CR21","volume-title":"WHO handbook for reporting results of cancer treatment","author":"WHO","year":"1979","unstructured":"WHO:WHO handbook for reporting results of cancer treatment. Geneva: WHO, 1979."}],"container-title":["Biotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01877428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01877428\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01877428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:57:18Z","timestamp":1586318238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01877428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["BF01877428"],"URL":"https:\/\/doi.org\/10.1007\/bf01877428","relation":{},"ISSN":["0921-299X","1573-8280"],"issn-type":[{"value":"0921-299X","type":"print"},{"value":"1573-8280","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}